Elperion Tablet (Eperisone Hydrochloride)

Adult dose

As eperisone hydrochloride, 50 mg should be orally administered three times a day after meals. Adjust dosage according to age and symptoms.

This medication should not be used in certain patients. Firstly, it should not be administered to patients with allergies to this drug or those suffering from myasthenia gravis. Additionally, as this medication contains lactose, it should not be used in patients with genetic issues such as lactose intolerance, galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption. When using this drug, caution is required when administering to patients with a history of drug allergies or patients with impaired liver function. Care is necessary as liver function may worsen. Rarely, shock reactions may occur during the use of this drug, so symptoms should be closely monitored and administration should be discontinued immediately if abnormalities arise. Liver function test results may increase, so regular checks should be performed, and appropriate measures should be taken if abnormalities are found. It may also affect kidney function, so it is important to pay close attention to proteinuria or blood test results. Blood abnormalities such as anemia may also occur, so monitoring is necessary. Neurological symptoms such as skin rashes, itching, insomnia, drowsiness, headaches, limb paralysis, or body rigidity or tremors may occur. Gastrointestinal symptoms may include nausea, vomiting, appetite loss, abdominal pain, constipation, and diarrhea, thus caution is required. Urinary symptoms may include difficulty urinating or a feeling of residual urine, and urinary incontinence may occur. Systemically, symptoms such as weakness, dizziness, and decreased muscle tone may appear. Rarely, symptoms such as facial flushing, sweating, and edema may occur. In severe cases, anaphylactic reactions or angioedema, and serious cutaneous adverse reactions such as toxic epidermal necrolysis syndrome, may occur, so if symptoms such as fever, erythema, blisters, itching, eye congestion, or stomatitis appear, administration should be stopped immediately and medical consultation should be sought. During the course of treatment with this drug, symptoms such as weakness, staggering, or drowsiness may occur, thus if severe, the dosage should be reduced or discontinued. Drowsiness or decreased concentration may occur, making it advisable to avoid driving or operating hazardous machinery. Care should be taken when using this drug in combination with similar drugs or certain muscle relaxants, as coordination disorders may occur when used together. Women who are pregnant or may become pregnant should use this drug only when the benefits of treatment outweigh the risks, as its safety has not been established. Nursing mothers should avoid administration if possible, and if it must be used, it is preferable to discontinue breastfeeding. Safety in children has not been sufficiently established, and experience is limited, hence caution is required. Elderly patients may have decreased bodily functions, so special attention, such as reducing dosages, is necessary.

Serious side effects

Shock, liver dysfunction (increased ALT, AST, ALP), kidney abnormalities (proteinuria, increased BUN), anemia, anaphylactic reactions, angioedema, toxic epidermal necrolysis and mucocutaneous ocular syndrome, fever, erythema, blisters, itching, eye congestion, stomatitis

Mild side effects

• Rash
• itching
• insomnia
• drowsiness
• headache
• rigidity of the body
• limb tremors
• nausea
• vomiting
• anorexia

This medication should be stored in a tightly sealed container to prevent air or moisture from entering, and it is best to store it at room temperature, between 1 to 30 degrees Celsius. This will help maintain the drug's effectiveness over time.

Appearance

White round sugar-coated tablet

Package unit

30 tablets/bottle, 500 tablets/bottle